Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00760630 · ClinicalTrials.gov registry record
Measurements to Assess Severity of Epicardial Stenoses
A clinical trial, sponsored by University of Cincinnati.
- Terminated
- Registry status
- 10
- Enrollment target
NCT00760630: Clinical Trial study, sponsored by University of Cincinnati.
NCT00760630 is a clinical trial that was terminated before completion, run by University of Cincinnati. The registered enrollment target is 10 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00760630 was terminated before completion, sponsored by University of Cincinnati.
- TERMINATED
- Registry status
- 10 participants
- Enrollment target
Study Summary
Newly developed diagnostic parameters have potential to differentiate between epicardial disease and microvascular dysfunction with the help of anatomical details and physiological endpoints and can be used in present clinical settings.
Interventions
- DEVICE FFR/CFR and IVUS
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2009-12 |
| Est. Completion | 2012-02-24 |
Why NCT00760630 stopped before completion
NCT00760630 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 10 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which FFR/CFR and IVUS is the first listed.
NCT00760630 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00760630 about?
NCT00760630 is a clinical study titled "Measurements to Assess Severity of Epicardial Stenoses". Newly developed diagnostic parameters have potential to differentiate between epicardial disease and microvascular dysfunction with the help of anatomical details and physiological endpoints and can be used in present clinical settings.
What is the current status of trial NCT00760630?
This trial is currently terminated. The enrollment target is 10 participants. The study started on 2009-12. Estimated completion is 2012-02-24.
What interventions are being tested in trial NCT00760630?
The interventions under investigation include: FFR/CFR and IVUS (DEVICE).
Who is sponsoring clinical trial NCT00760630?
This trial is sponsored by University of Cincinnati, which has 245 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00623389 · 10 participants · NA
Evaluation of an Advanced Lower Extremity Neuroprostheses
- NCT01241864 · 10 participants · Phase 2
Islet Transplantation in Type 1 Diabetic Kidney Allograft
- NCT01293214 · 10 participants · NA
Vascularized Composite Allotransplantation for Multiple Extremity Amputations
- NCT01474148 · 10 participants · NA
A Neuroprosthesis for Seated Posture and Balance
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia